Open Access iconOpen Access

ARTICLE

crossmark

The Implication of microRNAs as non-invasive biomarkers in 179 Egyptian breast cancer female patients

NADIA Z. SHAABAN1, NASHWA K. IBRAHIM2, HELEN N. SAADA2, FATMA H. EL-RASHIDY1, HEBATALLAH M. SHAABAN3, NERMEEN M. ELBAKARY2,*, AHMAD S. KODOUS1,2,*

1 Biochemistry Department, Faculty of Science, Alexandria University, P.O. Box 21568, Alexandria, Egypt
2 Radiation Biology Department, National Center for Radiation Research & Technology, Egyptian Atomic-Energy Authority, P.O. Box 8029, Cairo, Egypt
3 National Cancer Institute, Cairo University, P.O. Box 11796, Cairo, Egypt

* Corresponding Authors: Ahmad S. Kodous, email; Nermeen M. Elbakary, email

Oncology Research 2022, 30(6), 269-276. https://doi.org/10.32604/or.2022.027277

Abstract

Background: MicroRNAs (miRs) are small (19–25 nucleotides), non-protein coding RNAs that regulate gene expression, and thus play essential roles in cell cycle progression. The evidence has demonstrated that the expression of several miRs is dysregulated in human cancer. Methods: The study includes 179 female patients and 58 healthy women Patients were identified as luminal A, B, Her-2/neu, and basal-like, as well as classified into I, II, and III stages. Analysis of the expression fold change of miR-21 and miR-34a with molecular markers, including the oncogene Bcl-2 (B-cell lymphoma 2) and the tumor suppressor genes BRCA1 (breast cancer susceptibility gene 1), BRCA2 (breast cancer susceptibility gene 2), and the tumor suppressor protein p53, was carried out for all patients, pre- and postchemotherapy, and for all healthy women. Results: At diagnosis (pre-chemotherapy), miR-21 was up-regulated (p < 0.001), while miR-34a was down-regulated (p < 0.001). Post-chemotherapy, the expression of miR-21 decreased significantly (p < 0.001), while the expression of miR-34a increased significantly (p < 0.001). Conclusion: miR-21 and miR-34a may be helpful to non-invasive biomarkers to evaluate the response of breast cancer to chemotherapy.

Keywords


Cite This Article

APA Style
SHAABAN, N.Z., IBRAHIM, N.K., SAADA, H.N., EL-RASHIDY, F.H., SHAABAN, H.M. et al. (2022). The implication of micrornas as non-invasive biomarkers in 179 egyptian breast cancer female patients. Oncology Research, 30(6), 269-276. https://doi.org/10.32604/or.2022.027277
Vancouver Style
SHAABAN NZ, IBRAHIM NK, SAADA HN, EL-RASHIDY FH, SHAABAN HM, ELBAKARY NM, et al. The implication of micrornas as non-invasive biomarkers in 179 egyptian breast cancer female patients. Oncol Res. 2022;30(6):269-276 https://doi.org/10.32604/or.2022.027277
IEEE Style
N.Z. SHAABAN et al., "The Implication of microRNAs as non-invasive biomarkers in 179 Egyptian breast cancer female patients," Oncol. Res., vol. 30, no. 6, pp. 269-276. 2022. https://doi.org/10.32604/or.2022.027277



cc This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 952

    View

  • 536

    Download

  • 0

    Like

Share Link